Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/28/25 16:08 | 1/24/25 | HRMY | Health | Drug | Pharmaceutical Preparations | Dierks Jeffrey | PA | O | CHIEF CO | 10 | S.dm | -5,073 | 38.10 | 0 | -133 | -100 | 0 | D | ||||||||||||||
1/28/25 16:04 | 1/27/25 | HRMY | Health | Drug | Pharmaceutical Preparations | Kapadia Sandip | PA | O | CFO | 2 | S.d | -1,072 | 40.04 | 0 | -27 | -100 | 0 | D | ||||||||||||||
1/23/25 16:17 | 1/21/25 | HRMY | Health | Drug | Pharmaceutical Preparations | Dayno Jeffrey M. | PA | DO | P,CEO | 1 | S.d | -774 | 40.13 | 0 | -19 | -100 | 0 | D | ||||||||||||||
11/5/24 17:48 | 11/1/24 | HRMY | Health | Drug | Pharmaceutical Preparations | Valor IV Pharma Holdings, LLC | IL | T | 1 | S.m | -139,392 | 30.30 | 0 | -4,600 | 6,618 | D | ||||||||||||||||
11/5/24 16:05 | 11/1/24 | HRMY | Health | Drug | Pharmaceutical Preparations | Marshman Fund Trust II | FL | T | 1 | S.m | -139,392 | 30.30 | 0 | -4,600 | 6,051 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |